Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Effects of sildenafil and/or muscle derived stem cells on myocardial infarction

Authors: Judy SC Wang, Istvan Kovanecz, Dolores Vernet, Gaby Nolazco, George E Kopchok, Sheryl L Chow, Rodney A White, Nestor F Gonzalez-Cadavid

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

Previous studies have shown that long-term oral daily PDE 5 inhibitors (PDE5i) counteract fibrosis, cell loss, and the resulting dysfunction in tissues of various rat organs and that implantation of skeletal muscle-derived stem cells (MDSC) exerts some of these effects. PDE5i and stem cells in combination were found to be more effective in non-MI cardiac repair than each treatment separately. We have now investigated whether sildenafil at lower doses and MDSC, alone or in combination are effective to attenuate LV remodeling after MI in rats.

Methods

MI was induced in rats by ligature of the left anterior descending coronary artery. Treatment groups were: “Series A”: 1) untreated; 2) oral sildenafil 3 mg/kg/day from day 1; and “Series B”: intracardiac injection at day 7 of: 3) saline; 4) rat MDSC (106 cells); 5) as #4, with sildenafil as in #2. Before surgery, and at 1 and 4 weeks, the left ventricle ejection fraction (LVEF) was measured. LV sections were stained for collagen, myofibroblasts, apoptosis, cardiomyocytes, and iNOS, followed by quantitative image analysis. Western blots estimated angiogenesis and myofibroblast accumulation, as well as potential sildenafil tachyphylaxis by PDE 5 expression. Zymography estimated MMPs 2 and 9 in serum.

Results

As compared to untreated MI rats, sildenafil improved LVEF, reduced collagen, myofibroblasts, and circulating MMPs, and increased cardiac troponin T. MDSC replicated most of these effects and stimulated cardiac angiogenesis. Concurrent MDSC/sildenafil counteracted cardiomyocyte and endothelial cells loss, but did not improve LVEF or angiogenesis, and upregulated PDE 5.

Conclusions

Long-term oral sildenafil, or MDSC given separately, reduce the MI fibrotic scar and improve left ventricular function in this rat model. The failure of the treatment combination may be due to inducing overexpression of PDE5.
Appendix
Available only for authorised users
Literature
1.
go back to reference Porter KE, Turner NA: Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009, 123: 255-278. 10.1016/j.pharmthera.2009.05.002.CrossRefPubMed Porter KE, Turner NA: Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther. 2009, 123: 255-278. 10.1016/j.pharmthera.2009.05.002.CrossRefPubMed
2.
go back to reference Forte A, Della Corte A, De Feo M, Cerasuolo F, Cipollaro M: Role of myofibroblasts in vascular remodeling: focus on restenosis and aneurysm. Cardiovasc Res. 2010, 88: 395-405. 10.1093/cvr/cvq224.CrossRefPubMed Forte A, Della Corte A, De Feo M, Cerasuolo F, Cipollaro M: Role of myofibroblasts in vascular remodeling: focus on restenosis and aneurysm. Cardiovasc Res. 2010, 88: 395-405. 10.1093/cvr/cvq224.CrossRefPubMed
3.
go back to reference Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF: Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int. 2009, 103: 1396-1404. 10.1111/j.1464-410X.2008.08251.x.CrossRefPubMed Kovanecz I, Nolazco G, Ferrini MG, Toblli JE, Heydarkhan S, Vernet D, Rajfer J, Gonzalez-Cadavid NF: Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction. BJU Int. 2009, 103: 1396-1404. 10.1111/j.1464-410X.2008.08251.x.CrossRefPubMed
4.
go back to reference Toblli JE, Ferrini MG, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid NF: Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol Dial Transplant. 2009, 24: 2384-2391. 10.1093/ndt/gfp103.CrossRefPubMedPubMedCentral Toblli JE, Ferrini MG, Cao G, Vernet D, Angerosa M, Gonzalez-Cadavid NF: Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus. Nephrol Dial Transplant. 2009, 24: 2384-2391. 10.1093/ndt/gfp103.CrossRefPubMedPubMedCentral
5.
go back to reference Serrano AL, Muñoz-Cánoves P: Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res. 2010, 316: 3050-3058. 10.1016/j.yexcr.2010.05.035.CrossRefPubMed Serrano AL, Muñoz-Cánoves P: Regulation and dysregulation of fibrosis in skeletal muscle. Exp Cell Res. 2010, 316: 3050-3058. 10.1016/j.yexcr.2010.05.035.CrossRefPubMed
6.
go back to reference Gonzalez-Cadavid NF: Mechanisms of penile fibrosis. J Sex Med. 2009, 3: 353-362.CrossRef Gonzalez-Cadavid NF: Mechanisms of penile fibrosis. J Sex Med. 2009, 3: 353-362.CrossRef
7.
go back to reference Gajarsa JJ, Kloner RA: Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011, 16: 13-21. 10.1007/s10741-010-9181-7.CrossRefPubMed Gajarsa JJ, Kloner RA: Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011, 16: 13-21. 10.1007/s10741-010-9181-7.CrossRefPubMed
8.
go back to reference Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L: Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Exp Clin Cardiol. 2011, 16: e30-e35.PubMedPubMedCentral Kukreja RC, Salloum FN, Das A, Koka S, Ockaili RA, Xi L: Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases. Exp Clin Cardiol. 2011, 16: e30-e35.PubMedPubMedCentral
9.
10.
go back to reference Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R: Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010, 87: 406-423. 10.1093/cvr/cvq129.CrossRefPubMed Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R: Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010, 87: 406-423. 10.1093/cvr/cvq129.CrossRefPubMed
11.
go back to reference Kumar P, Francis GS, Tang WH: Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications. Nat Rev Cardiol. 2009, 6: 349-355. 10.1038/nrcardio.2009.32.CrossRefPubMed Kumar P, Francis GS, Tang WH: Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications. Nat Rev Cardiol. 2009, 6: 349-355. 10.1038/nrcardio.2009.32.CrossRefPubMed
12.
go back to reference Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ, Hoke NN, Roy SK, Brown WR, Prabhakar S, Kukreja RC: Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol. 2008, 294: H1398-H1406.CrossRefPubMed Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ, Hoke NN, Roy SK, Brown WR, Prabhakar S, Kukreja RC: Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol. 2008, 294: H1398-H1406.CrossRefPubMed
13.
go back to reference Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC: ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol. 2009, 296: H1236-H1243. 10.1152/ajpheart.00100.2009.CrossRefPubMedPubMedCentral Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC: ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol. 2009, 296: H1236-H1243. 10.1152/ajpheart.00100.2009.CrossRefPubMedPubMedCentral
14.
go back to reference Pérez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, Chiappe de Cingolani G, Yang XP, Cingolani HE: Phosphodiesterase 5A inhibition induces Na+/H + exchanger blockade and protection against myocardial infarction. Hypertension. 2007, 49: 1095-1103. 10.1161/HYPERTENSIONAHA.107.087759.CrossRefPubMed Pérez NG, Piaggio MR, Ennis IL, Garciarena CD, Morales C, Escudero EM, Cingolani OH, Chiappe de Cingolani G, Yang XP, Cingolani HE: Phosphodiesterase 5A inhibition induces Na+/H + exchanger blockade and protection against myocardial infarction. Hypertension. 2007, 49: 1095-1103. 10.1161/HYPERTENSIONAHA.107.087759.CrossRefPubMed
15.
go back to reference Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC: Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol. 2007, 42: 453-458. 10.1016/j.yjmcc.2006.10.015.CrossRefPubMedPubMedCentral Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC: Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol. 2007, 42: 453-458. 10.1016/j.yjmcc.2006.10.015.CrossRefPubMedPubMedCentral
16.
go back to reference Koka S, Kukreja RC: Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor. Mol Cell Pharmacol. 2010, 2: 173-178.PubMedPubMedCentral Koka S, Kukreja RC: Attenuation of Doxorubicin-induced Cardiotoxicity by Tadalafil: A Long Acting Phosphodiesterase-5 Inhibitor. Mol Cell Pharmacol. 2010, 2: 173-178.PubMedPubMedCentral
17.
go back to reference Koneru S, Varma Penumathsa S, Thirunavukkarasu M, Vidavalur R, Zhan L, Singal PK, Engelman RM, Das DK, Maulik N: Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med. 2008, 12: 2651-2664. 10.1111/j.1582-4934.2008.00319.x.CrossRefPubMedPubMedCentral Koneru S, Varma Penumathsa S, Thirunavukkarasu M, Vidavalur R, Zhan L, Singal PK, Engelman RM, Das DK, Maulik N: Sildenafil-mediated neovascularization and protection against myocardial ischaemia reperfusion injury in rats: role of VEGF/angiopoietin-1. J Cell Mol Med. 2008, 12: 2651-2664. 10.1111/j.1582-4934.2008.00319.x.CrossRefPubMedPubMedCentral
18.
go back to reference Sesti C, Florio V, Johnson EG, Kloner RA: The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2007, 19: 55-61. 10.1038/sj.ijir.3901497.CrossRefPubMed Sesti C, Florio V, Johnson EG, Kloner RA: The phosphodiesterase-5 inhibitor tadalafil reduces myocardial infarct size. Int J Impot Res. 2007, 19: 55-61. 10.1038/sj.ijir.3901497.CrossRefPubMed
19.
go back to reference Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC: Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.Circulation 2009, 120:S31-36. Erratum in. Circulation. 2009, 120: e139-CrossRef Salloum FN, Chau VQ, Hoke NN, Abbate A, Varma A, Ockaili RA, Toldo S, Kukreja RC: Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide.Circulation 2009, 120:S31-36. Erratum in. Circulation. 2009, 120: e139-CrossRef
20.
go back to reference Shan X, Quaile MP, Monk JK, French B, Cappola TP, Margulies KB: Differential Expression of PDE5 in Failing and Non-Failing Human Myocardium. Circ Heart Fail. 2012, 5: 79-86. 10.1161/CIRCHEARTFAILURE.111.961706.CrossRefPubMedPubMedCentral Shan X, Quaile MP, Monk JK, French B, Cappola TP, Margulies KB: Differential Expression of PDE5 in Failing and Non-Failing Human Myocardium. Circ Heart Fail. 2012, 5: 79-86. 10.1161/CIRCHEARTFAILURE.111.961706.CrossRefPubMedPubMedCentral
21.
go back to reference Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N: Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008, 20: 202-212. 10.1038/sj.ijir.3901612.CrossRefPubMed Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N: Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008, 20: 202-212. 10.1038/sj.ijir.3901612.CrossRefPubMed
22.
go back to reference Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N: Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008, 101: 203-210.PubMed Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N: Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int. 2008, 101: 203-210.PubMed
23.
go back to reference Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF: Long-term continuous treatment with sildenafil ameliorates aging related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod. 2007, 76: 915-923. 10.1095/biolreprod.106.059642.CrossRefPubMed Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF: Long-term continuous treatment with sildenafil ameliorates aging related erectile dysfunction and the underlying corporal fibrosis in the rat. Biol Reprod. 2007, 76: 915-923. 10.1095/biolreprod.106.059642.CrossRefPubMed
24.
go back to reference Magheli A, Burnett AL: Medscape. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol. 2009, 6: 415-427. 10.1038/nrurol.2009.126.CrossRefPubMed Magheli A, Burnett AL: Medscape. Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol. 2009, 6: 415-427. 10.1038/nrurol.2009.126.CrossRefPubMed
25.
go back to reference Hemnes AR, Zaiman A, Champion HC: PDE 5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol. 2008, 294: L24-L33.CrossRefPubMed Hemnes AR, Zaiman A, Champion HC: PDE 5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol. 2008, 294: L24-L33.CrossRefPubMed
26.
go back to reference Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ: Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol. 2009, 29: 274-282. 10.1159/000158635.CrossRefPubMed Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ: Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol. 2009, 29: 274-282. 10.1159/000158635.CrossRefPubMed
27.
go back to reference Gonzalez-Cadavid NF, Rajfer J: Treatment of Peyronie's disease with PDE 5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010, 7: 215-221. 10.1038/nrurol.2010.24.CrossRefPubMed Gonzalez-Cadavid NF, Rajfer J: Treatment of Peyronie's disease with PDE 5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010, 7: 215-221. 10.1038/nrurol.2010.24.CrossRefPubMed
28.
go back to reference Mazo M, Pelacho B, Prósper F: Stem cell therapy for chronic myocardial infarction. J Cardiovasc Transl Res. 2010, 3: 79-88. 10.1007/s12265-009-9159-9.CrossRefPubMed Mazo M, Pelacho B, Prósper F: Stem cell therapy for chronic myocardial infarction. J Cardiovasc Transl Res. 2010, 3: 79-88. 10.1007/s12265-009-9159-9.CrossRefPubMed
29.
go back to reference Lin YC, Leu S, Sun CK, Yen CH, Kao YH, Chang LT, Tsai TH, Chua S, Fu M, Ko SF, Wu CJ, Lee FY, Yip HK: Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med. 2010, 8: 88-10.1186/1479-5876-8-88.CrossRefPubMedPubMedCentral Lin YC, Leu S, Sun CK, Yen CH, Kao YH, Chang LT, Tsai TH, Chua S, Fu M, Ko SF, Wu CJ, Lee FY, Yip HK: Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med. 2010, 8: 88-10.1186/1479-5876-8-88.CrossRefPubMedPubMedCentral
30.
go back to reference Hoke NN, Salloum FN, Kass DA, Das A, Kukreja RC: Preconditioning by Phosphodiesterase-5 Inhibition Improves Therapeutic Efficacy of Adipose Derived Stem Cells Following Myocardial Infarction in Mice. Stem Cells. 2012, 30: 326-335. 10.1002/stem.789.CrossRefPubMed Hoke NN, Salloum FN, Kass DA, Das A, Kukreja RC: Preconditioning by Phosphodiesterase-5 Inhibition Improves Therapeutic Efficacy of Adipose Derived Stem Cells Following Myocardial Infarction in Mice. Stem Cells. 2012, 30: 326-335. 10.1002/stem.789.CrossRefPubMed
31.
go back to reference Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, Parveen S, Nikonoff LE, Kots AY, Murad F: Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci USA. 2008, 105: 18924-18929. 10.1073/pnas.0810230105.CrossRefPubMedPubMedCentral Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, Parveen S, Nikonoff LE, Kots AY, Murad F: Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci USA. 2008, 105: 18924-18929. 10.1073/pnas.0810230105.CrossRefPubMedPubMedCentral
32.
go back to reference Ybarra N, del Castillo JR, Troncy E: Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes. Nitric Oxide. 2011, 24: 25-33. 10.1016/j.niox.2010.09.008.CrossRefPubMed Ybarra N, del Castillo JR, Troncy E: Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes. Nitric Oxide. 2011, 24: 25-33. 10.1016/j.niox.2010.09.008.CrossRefPubMed
33.
go back to reference Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH, Huard J: Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther. 2005, 12: 1130-1141. 10.1016/j.ymthe.2005.07.686.CrossRefPubMed Oshima H, Payne TR, Urish KL, Sakai T, Ling Y, Gharaibeh B, Tobita K, Keller BB, Cummins JH, Huard J: Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther. 2005, 12: 1130-1141. 10.1016/j.ymthe.2005.07.686.CrossRefPubMed
34.
go back to reference Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H, Huard J: A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol. 2007, 50: 1677-1684. 10.1016/j.jacc.2007.04.100.CrossRefPubMed Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H, Huard J: A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol. 2007, 50: 1677-1684. 10.1016/j.jacc.2007.04.100.CrossRefPubMed
35.
go back to reference Okada M, Payne TR, Zheng B, Oshima H, Momoi N, Tobita K, Keller BB, Phillippi JA, Péault B, Huard J: Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol. 2008, 52: 1869-1880. 10.1016/j.jacc.2008.07.064.CrossRefPubMedPubMedCentral Okada M, Payne TR, Zheng B, Oshima H, Momoi N, Tobita K, Keller BB, Phillippi JA, Péault B, Huard J: Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J Am Coll Cardiol. 2008, 52: 1869-1880. 10.1016/j.jacc.2008.07.064.CrossRefPubMedPubMedCentral
36.
go back to reference Tamaki T, Akatsuka A, Okada Y, Uchiyama Y, Tono K, Wada M, Hoshi A, Iwaguro H, Iwasaki H, Oyamada A, Asahara T: Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One. 2008, 3: e1789-10.1371/journal.pone.0001789.CrossRefPubMedPubMedCentral Tamaki T, Akatsuka A, Okada Y, Uchiyama Y, Tono K, Wada M, Hoshi A, Iwaguro H, Iwasaki H, Oyamada A, Asahara T: Cardiomyocyte formation by skeletal muscle-derived multi-myogenic stem cells after transplantation into infarcted myocardium. PLoS One. 2008, 3: e1789-10.1371/journal.pone.0001789.CrossRefPubMedPubMedCentral
37.
go back to reference Gharaibeh B, Lu A, Tebbets J, Zheng B, Feduska J, Crisan M, Péault B, Cummins J, Huard J: Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 2008, 3: 1501-1509. 10.1038/nprot.2008.142.CrossRefPubMed Gharaibeh B, Lu A, Tebbets J, Zheng B, Feduska J, Crisan M, Péault B, Cummins J, Huard J: Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique. Nat Protoc. 2008, 3: 1501-1509. 10.1038/nprot.2008.142.CrossRefPubMed
38.
go back to reference Nolazco G, Kovanecz I, Vernet D: Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 2008, 101: 1156-1164. 10.1111/j.1464-410X.2008.07507.x.CrossRefPubMed Nolazco G, Kovanecz I, Vernet D: Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 2008, 101: 1156-1164. 10.1111/j.1464-410X.2008.07507.x.CrossRefPubMed
39.
go back to reference Ho MH, Heydarkhan S, Vernet D, Kovanecz I, Ferrini MG, Bhatia NN, Gonzalez-Cadavid NF: Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol. 2009, 114: 300-309. 10.1097/AOG.0b013e3181af6abd.CrossRefPubMedPubMedCentral Ho MH, Heydarkhan S, Vernet D, Kovanecz I, Ferrini MG, Bhatia NN, Gonzalez-Cadavid NF: Stimulating vaginal repair in rats through skeletal muscle-derived stem cells seeded on small intestinal submucosal scaffolds. Obstet Gynecol. 2009, 114: 300-309. 10.1097/AOG.0b013e3181af6abd.CrossRefPubMedPubMedCentral
40.
go back to reference Tsao J, Vernet D, Gelfand R, Kovanecz I, Nolazco G, Gonzalez-Cadavid NF: Myostatin inactivation affects myogenesis by muscle derived stem cells in vitro and in the mdx mouse. 2009, Kansas City, Missouri, USA: Military Health Research Forum Tsao J, Vernet D, Gelfand R, Kovanecz I, Nolazco G, Gonzalez-Cadavid NF: Myostatin inactivation affects myogenesis by muscle derived stem cells in vitro and in the mdx mouse. 2009, Kansas City, Missouri, USA: Military Health Research Forum
41.
go back to reference Brown RD, Jones GM, Laird RE, Hudson P, Long S: Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem Biophys Re Commun. 2007, 362: 200-235. 10.1016/j.bbrc.2007.08.003.CrossRef Brown RD, Jones GM, Laird RE, Hudson P, Long S: Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem Biophys Re Commun. 2007, 362: 200-235. 10.1016/j.bbrc.2007.08.003.CrossRef
42.
go back to reference Gómez-Pinedo U, Rodrigo R, Cauli O, Herraiz S, Garcia-Verdugo JM, Pellicer B, Pellicer A, Felipo V: cGMP modulates stem cells differentiation to neurons in brain in vivo. Neuroscience. 2010, 165: 1275-1283. 10.1016/j.neuroscience.2009.11.046.CrossRefPubMed Gómez-Pinedo U, Rodrigo R, Cauli O, Herraiz S, Garcia-Verdugo JM, Pellicer B, Pellicer A, Felipo V: cGMP modulates stem cells differentiation to neurons in brain in vivo. Neuroscience. 2010, 165: 1275-1283. 10.1016/j.neuroscience.2009.11.046.CrossRefPubMed
43.
go back to reference Kovanecz I, Rivera S, Nolazco G, Vernet D, Rajfer J, Gonzalez-Cadavid NF: Long term daily molsidomine and low dose sildenafil, and corporal implantation of muscle derived stem cells (MDSC), alone or in combination, prevent corporal venooclusive dysfunction (CVOD) in a rat model of cavernosal nerve damage. J Urol. 2011, 185: e452-CrossRef Kovanecz I, Rivera S, Nolazco G, Vernet D, Rajfer J, Gonzalez-Cadavid NF: Long term daily molsidomine and low dose sildenafil, and corporal implantation of muscle derived stem cells (MDSC), alone or in combination, prevent corporal venooclusive dysfunction (CVOD) in a rat model of cavernosal nerve damage. J Urol. 2011, 185: e452-CrossRef
44.
go back to reference Muirhead GJ, Rance DJ, Walker DK, Wastall P: Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil. Br J Clin Pharmacol. 2002, 53: 13S-20S.CrossRefPubMedPubMedCentral Muirhead GJ, Rance DJ, Walker DK, Wastall P: Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil. Br J Clin Pharmacol. 2002, 53: 13S-20S.CrossRefPubMedPubMedCentral
45.
go back to reference Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966, 50: 219-244.PubMed Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE: Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep. 1966, 50: 219-244.PubMed
46.
go back to reference Chau VQ, Salloum FN, Hoke NN, Abbate A, Kukreja RC: Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. Am J Physiol Heart Circ Physiol. 2011, 300: H2272-H2279. 10.1152/ajpheart.00654.2010.CrossRefPubMedPubMedCentral Chau VQ, Salloum FN, Hoke NN, Abbate A, Kukreja RC: Mitigation of the progression of heart failure with sildenafil involves inhibition of RhoA/Rho-kinase pathway. Am J Physiol Heart Circ Physiol. 2011, 300: H2272-H2279. 10.1152/ajpheart.00654.2010.CrossRefPubMedPubMedCentral
47.
go back to reference Ferrini MG, Rivera S, Moon J, Vernet D, Rajfer J, Gonzalez-Cadavid NF: The Genetic Inactivation of Inducible Nitric Oxide Synthase (iNOS) Intensifies Fibrosis and Oxidative Stress in the Penile Corpora Cavernosa in Type 1 Diabetes. J Sex Med. 2010, 7: 3033-3044. 10.1111/j.1743-6109.2010.01884.x.CrossRefPubMed Ferrini MG, Rivera S, Moon J, Vernet D, Rajfer J, Gonzalez-Cadavid NF: The Genetic Inactivation of Inducible Nitric Oxide Synthase (iNOS) Intensifies Fibrosis and Oxidative Stress in the Penile Corpora Cavernosa in Type 1 Diabetes. J Sex Med. 2010, 7: 3033-3044. 10.1111/j.1743-6109.2010.01884.x.CrossRefPubMed
48.
go back to reference Zhang M, Takimoto E, Hsu S, Lee DI, Nagayama T, Danner T, Koitabashi N, Barth AS, Bedja D, Gabrielson KL, Wang Y, Kass DA: Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. J Am Coll Cardiol. 2010, 56: 2021-2030. 10.1016/j.jacc.2010.08.612.CrossRefPubMedPubMedCentral Zhang M, Takimoto E, Hsu S, Lee DI, Nagayama T, Danner T, Koitabashi N, Barth AS, Bedja D, Gabrielson KL, Wang Y, Kass DA: Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. J Am Coll Cardiol. 2010, 56: 2021-2030. 10.1016/j.jacc.2010.08.612.CrossRefPubMedPubMedCentral
49.
go back to reference Lin G, Xin ZC, Lue TF, Lin CS: Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol. 2003, 170: S15-S18. 10.1097/01.ju.0000075500.11519.e8.CrossRefPubMed Lin G, Xin ZC, Lue TF, Lin CS: Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol. 2003, 170: S15-S18. 10.1097/01.ju.0000075500.11519.e8.CrossRefPubMed
50.
go back to reference Musicki B, Champion HC, Becker RE, Kramer MF, Liu T, Sezen SF, Burnett AL: In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect. J Urol. 2005, 174: 1493-1496. 10.1097/01.ju.0000173006.47623.2c.CrossRefPubMed Musicki B, Champion HC, Becker RE, Kramer MF, Liu T, Sezen SF, Burnett AL: In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect. J Urol. 2005, 174: 1493-1496. 10.1097/01.ju.0000173006.47623.2c.CrossRefPubMed
51.
go back to reference Li Y, Huard J: Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002, 161: 895-907. 10.1016/S0002-9440(10)64250-2.CrossRefPubMedPubMedCentral Li Y, Huard J: Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol. 2002, 161: 895-907. 10.1016/S0002-9440(10)64250-2.CrossRefPubMedPubMedCentral
52.
go back to reference Ono Y, Sensui H, Okutsu S, Nagatomi R: Notch2 negatively regulates myofibroblastic differentiation of myoblasts. J Cell Physiol. 2007, 210: 358-369. 10.1002/jcp.20838.CrossRefPubMed Ono Y, Sensui H, Okutsu S, Nagatomi R: Notch2 negatively regulates myofibroblastic differentiation of myoblasts. J Cell Physiol. 2007, 210: 358-369. 10.1002/jcp.20838.CrossRefPubMed
53.
go back to reference Carlson S, Trial J, Soeller C, Entman ML: Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc Res. 2011, 91: 99-107. 10.1093/cvr/cvr061.CrossRefPubMedPubMedCentral Carlson S, Trial J, Soeller C, Entman ML: Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc Res. 2011, 91: 99-107. 10.1093/cvr/cvr061.CrossRefPubMedPubMedCentral
54.
go back to reference Vernet D, Magee T, Qian A, Nolazco G, Rajfer J, Gonzalez-Cadavid N: Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells. J Sex Med. 2006, 3: 84-94. 10.1111/j.1743-6109.2005.00197.x. discussion 94–95CrossRefPubMed Vernet D, Magee T, Qian A, Nolazco G, Rajfer J, Gonzalez-Cadavid N: Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells. J Sex Med. 2006, 3: 84-94. 10.1111/j.1743-6109.2005.00197.x. discussion 94–95CrossRefPubMed
55.
go back to reference Dorn GW: Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol. 2009, 6: 283-291. 10.1038/nrcardio.2009.12.CrossRefPubMed Dorn GW: Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol. 2009, 6: 283-291. 10.1038/nrcardio.2009.12.CrossRefPubMed
56.
go back to reference Ludwig M, Steinhoff G, Li J: The regenerative potential of angiotensin AT(2) receptor in cardiac repair. Can J Physiol Pharmacol. 2012, 90: 287-293. 10.1139/y11-108.CrossRefPubMed Ludwig M, Steinhoff G, Li J: The regenerative potential of angiotensin AT(2) receptor in cardiac repair. Can J Physiol Pharmacol. 2012, 90: 287-293. 10.1139/y11-108.CrossRefPubMed
57.
go back to reference Qian C, Schoemaker RG, van Gilst WH, Roks AJ: The role of the rennin angiotensin-aldosterone system in cardiovascular progenitor cell function. Clin Sci (Lond). 2009, 116: 301-314. 10.1042/CS20080157.CrossRef Qian C, Schoemaker RG, van Gilst WH, Roks AJ: The role of the rennin angiotensin-aldosterone system in cardiovascular progenitor cell function. Clin Sci (Lond). 2009, 116: 301-314. 10.1042/CS20080157.CrossRef
58.
go back to reference Ma TK, Kam KK, Yan BP, Lam YY: Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010, 160: 1273-1292. 10.1111/j.1476-5381.2010.00750.x.CrossRefPubMedPubMedCentral Ma TK, Kam KK, Yan BP, Lam YY: Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010, 160: 1273-1292. 10.1111/j.1476-5381.2010.00750.x.CrossRefPubMedPubMedCentral
Metadata
Title
Effects of sildenafil and/or muscle derived stem cells on myocardial infarction
Authors
Judy SC Wang
Istvan Kovanecz
Dolores Vernet
Gaby Nolazco
George E Kopchok
Sheryl L Chow
Rodney A White
Nestor F Gonzalez-Cadavid
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-159

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.